The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. During the next five years, with investments, CDC’s efforts to combat C. difficile infections and antibiotic resistance under the National Strategy to Combat Antibiotic Resistant Bacteria,
CDC’s Dr. Scott Fridkin Senior Advisor for Antibiotic Resistance in Health care Today CDC released its latest Vital Signs report, which includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing. The report includes recommendations that would impact how health care
Guest Author: Sally M. Hess, CIC, MPH Manager, Infection Prevention, University of Vermont Medical Center Chair, APIC 2015 Annual Conference Committee AAhh…..It’s the time of year here in New England that I anticipate the coming of warmer days; we are finally seeing green leaves and flowers! It’s also the time of year I start getting
Guest Author – Jason G. Newland, MD MEd FPIDS Medical Director of Patient Safety and Systems Reliability Children’s Mercy Hospitals & Clinics, Kansas City, Missouri Antibiotic resistance is one of the nation’s most pressing public health threats. Yesterday CDC led several important discussions at the White House Forum on Antibiotic Stewardship. This forum is a
Author: CDC The White House is convening the Forum on Antibiotic Stewardship on Tuesday, June 2, 2015 to bring together key human and animal health constituencies involved in the development, promotion, and implementation of activities to improve antib…
Antibiotic resistance, the ability of bacteria to resist the effects of drugs, is perhaps the single most important infectious disease threat of our time. Although some people are at greater risk than others, no one can completely avoid the risk of antibiotic-resistant infections. These infections affect real people and they can be horrible for patients. […]
Guest Author: Jennie L. Mayfield, BSN, MPH, CIC2014 President, Association for Professionals in Infection Control and Epidemiology (APIC) A retrospective study from The University of Texas College of Pharmacy published in the October issue of the American Journal of Infection Control (AJIC), found that C. difficile infections (CDI) nearly doubled from 2001 to 2010 in […]
National Strategy to Combat Antibiotic-Resistant Bacteria The announcement Thursday morning of the President’s Executive Order and the National Strategy to Combat Antibiotic-Resistant Bacteria marks the administration’s response to one of the most urgent health threats facing us today – antibiotic resistance. Read more of the original post
Guest Author: Kyle B. Enfield, MD, Assistant Professor of Medicine, Assistant Hospital Epidemiologist, Medical Director, Medical Intensive Care Unit, University of Virginia Infections due to carbapenem-resistant Enterobacteriaceae (CRE) are on the rise…
Despite Progress, three-quarters of a million infections threaten hospital patients each year National and state data detail threat of healthcare-associated infections and opportunities for further improvements. CDC released two reports today – one, …
Author: Rear Admiral Boris D. Lushniak, MD, MPH Acting Surgeon General Antibiotics are powerful tools for fighting illness and disease, but some of these drugs are being rendered less effective due to overprescribing, misuse, and bacterial evolution. M…
Author – John Jernigan, M.D., director of CDC’s Office of Prevention Research and Evaluation and head of CDC’s Prevention Epicenters Program. I am excited to announce the results of the REDUCE MRSA study which evaluated three current strategies f…
Susan Huang, M.D., M.P.H., lead author of the REDUCE MRSA study and Associate Professor at the University of California Irvine School of Medicine and Medical Director of Epidemiology and Infection Prevention at UC Irvine Health For years, we have searc…
The REDUCE MRSA trial was published in today’s New England Journal of Medicine and took place in two stages from 2009-2011. A multidisciplinary team from the University of California, Irvine, Harvard Pilgrim Health Care Institute, Hospital Corporatio…
Guest Author – Dr. Currie Montefiore Medical Center, University Hospital and Academic Medical Center for the Albert Einstein College of Medicine Today I would like to discuss a highly successful patient safety intervention designed to reduce the prev…
